Predictors of type 2 diabetes remission in the Diabetes Remission Clinical Trial (DiRECT).
George ThomC-M MessowW S LeslieA C BarnesN BrosnahanL McCombieA Al-MrabehS ZhyzhneuskayaP WelshNaveed SattarR TaylorM E J LeanPublished in: Diabetic medicine : a journal of the British Diabetic Association (2020)
Other than weight loss, most predictors were modest, and not sufficient to identify subgroups for which remission was not a worthwhile target.
Keyphrases
- type diabetes
- clinical trial
- disease activity
- weight loss
- glycemic control
- ulcerative colitis
- cardiovascular disease
- bariatric surgery
- rheumatoid arthritis
- systemic lupus erythematosus
- randomized controlled trial
- insulin resistance
- roux en y gastric bypass
- study protocol
- double blind
- open label
- phase iii
- skeletal muscle
- obese patients